Counselors in Somerdale, NJ Accepting Medicare

4 Counselors found. Showing 1 - 4

Angela Saliba, LCADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 10 Somerdale Square, 1200 South White Horse Pike, Somerdale, NJ 08083 Phone: 856-679-2500    Fax: 856-282-1608

Viktoria Kristbergs, LCADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 10 Somerdale Square, 1200 South White Horse Pike, Somerdale, NJ 08083 Phone: 856-679-2500    Fax: 856-282-1608

Samantha Helen Galson, MA, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1723 Briarwood Dr, Somerdale, NJ 08083 Phone: 609-410-0084

Laura Fidorowicz, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 10 Somerdale Square, 1200 South White Horse Pike, Somerdale, NJ 08083 Phone: 855-740-1921

News Archive

FARI and The Cooper Institute publish new research paper on omega-3s and heart rate recovery

The Fatty Acid Research Institute (FARI) has published a new research paper in conjunction with The Cooper Institute on omega-3s and heart rate recovery.

China reports 2 more cases of H7N9; Researchers continue to investigate transmission routes

"China has found two more cases of a new strain of bird flu and one of the victims has died, state media said on Wednesday, bringing to nine the number of confirmed human infections from the previously unknown flu type," Reuters reports (Blanchard/Kelland, 4/3).

Metabolon agrees to provide biochemical profiling services to Human Longevity

Metabolon, Inc., the world's leading commercial-stage metabolomics company, announces the signing of an agreement with newly-launched Human Longevity Inc., whereby Metabolon will provide biochemical profiling services to assist HLI in its mission to tackle diseases of aging by building the world's largest and most complete human genotype, microbiome and phenotype database.

Pico-Tesla commences enrollment in its Magneceutical therapy study for type 2 diabetes

Pico-Tesla, The Magneceutical™ Therapy Company, announced today that it has enrolled the first seven patients for a randomized, double-blind, placebo-controlled Pilot Study of persons who have type 2 diabetes, the most common form of diabetes. The Pilot Study seeks to determine whether the application of magnetic fields generated by the Company's patented Resonator™ system can be effective as an adjunctive therapy to oral medications in reducing hemoglobin A1c levels.

Read more Medical News

› Verified 6 days ago